Home Query References Browse Contact

8 patient data entries in database for clusters 1 and 1 in age group "adult".

Entry
#
Mutations
allele 1allele 2
Clinical representationSymptomsAge groupAge of onsetAge of patientAge of deathReference
6G848S1
A143V1
Ataxia, peripheral neuropathy, hearing loss, abnormal MRI, COX deficiency, developmental delay, seizure, delayed gastric emptying, CPK abnormalities, sister died at 2.5 years. 111% mtDNA copy number in blood. Patient II-49.
-movement disorder (ataxia)
-peripheral neuropathy
-developmental delay
-delayed gastric emptying
-CPK abnormalities
-hearing loss
adult
n/a38n/aTang et al, 2011;

[view data]

76W918R1
M430L1
PEO, muscle weakness, and later onset levodopa-responsive pseudo-orthostatic tremor with Parkinsonism.
-muscle weakness
-PEO
-parkinson's disease
-tremor
adult
30n/an/aInvernizzi et al, 2008;

[view data]

77W918R1
M430L1
Onset at 32 years with ptosis, PEO.
-ptosis
-PEO
adult
32n/an/aFerreira et al, 2011;

[view data]

337R953C1
R953C1
gait abnormalities and PEO, cognitive impairment and depressive and psychotic symptoms, masked face, bradykinesia, action tremor, stooped posture, rigidity, complete ophthalmoplegia, and mild proximal limb weakness, sensory polyneuropathy, myopathy, mild cardiomyopathy, Multiple mtDNA deletions in muscle
-polyneuropathy
-myopathy
-PEO
-ophthalmoplegia
-tremor
adult
2035n/aGurgel-Giannetti et al, 2012;

[view data]

406R964C1
R964C1
34-year-old HIV-1–infected Thai woman who had been asymptomatic until the development of Pneumocystis jiroveci pneumonia. She had suffered from severe lactic acidosis after 1 year of use of d4T and lamivudine (3TC). Her peak lactate level was 67 mg/dL, and paresthesia was still present in both legs after 15 years of cessation of d4T treatment. Severe lactic acidosis induced by 1 year of treatment with d4T.
-lactic acidosis
adult
n/a34n/aYamanaka et al, 2007;

[view data]

517S1104C1
G848S1
Ataxia, Dementia, Peripheral neuropathy, Areflexia, Myopathy, fatigue, depression, Ophthalmoplegia, Dysarthria, Osteoporosis, arPEO.
-movement disorder (ataxia)
-peripheral neuropathy
-myopathy
-PEO
-ophthalmoplegia
-dementia
-dysarthria
-areflexia
adult
2259n/aLax et al, 2012b;

[view data]

574G848S1
S1104C1
The patient first presented at the age of 22 years with left-sided ptosis, which slowly progressed over the next 20 years to an almost complete ophthalmoplegia. He developed proximal muscle weakness at age 50 and his first Parkinsonian features at age 51. rigidity, tremor, bradykinesia and difficulty performing fine motor tasks. Proximal myopathy. sensorimotor neuropathy. Dysphagia.
-muscle weakness
-myopathy
-ptosis
-ophthalmoplegia
-dysphagia
-tremor
adult
225759Betts-Henderson et al, 2009;

[view data]

609G923D1
G923D1
adPEO.
-PEO
adult
n/a32n/aLamantea et al, 2002;

[view data]

1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details.

Number of displayed patient cases: 8
Avg age of onset in displayed cases: 28.8
Std dev in onset in displayed cases: 6.2

Search criteria for patient entries:
Mutations Entry IDs Clusters Reference Residue range
Patients for cluster combinations:
First cluster: Second cluster:
Age group: Any Infantile Childhood Juvenile Adult
:.: Privacy Statement :.: Disclaimer :.: Contact Information :.: